Fred Aslan - Insider Trading & Ownership

Location
C/O Artiva Biotherapeutics, Inc., 4747 Executive Drive, Suite 1150, San Diego, CA
Summary
The estimated net worth of Fred Aslan is at least $1.16M dollars as of November 17, 2025. Fred Aslan is the President and CEO, Director of Artiva Biotherapeutics, Inc. and owns shares of Artiva Biotherapeutics, Inc. (ARTV) stock worth about $1.16M.
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Fred Aslan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARTV Artiva Biotherapeutics, Inc. President and CEO, Director $1.16M -$91.1K -7.27% Nov 15, 2025

Insider Transactions Reported by Fred Aslan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.